Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Liver Neoplasms × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

OTHER 9 NIH 4 OTHER_GOV 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 2 Squamous Intraepithelial Lesions 1 Myoma 1 Menorrhagia 1 Lung Neoplasms 1 Liver Neoplasms 1 Leiomyoma 1 HIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-Grade Squamous Intraepithelial Lesions 1 Esophageal Squamous Cell Neoplasia (ESCN) 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Sorafenib 20 Bevacizumab 13 pembrolizumab 9 durvalumab 7 Ipilimumab 6 Talaporfin 5 Nivolumab 5 Drug Therapy 5 spartalizumab 4 lenvatinib 4 atezolizumab 4 regorafenib 3 derazantinib 3 Ramucirumab 3 Photochemotherapy 3 Leucovorin 3 Injections 3 Fluorouracil 3 Doxorubicin 3 tremelimumab 2 toripalimab 2 seocalcitol 2 phosphomannopentaose sulfate 2 liposomal doxorubicin 2 exatecan 2 brivanib 2 Phototherapy 2 Oxaliplatin 2 Oncolytic Virotherapy 2 Irinotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00510627 2017-03-03

Prometheus

Boston Scientific Corporation

Phase 4 Withdrawn

Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡